Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...

Though popular weight loss jabs like Ozempic and Wegovy have been deemed safe and effective by the FDA, concerning side ...

Of the total ER visits, nearly 70% involved GI issues, 15% of which led to hospitalization, according to a new study.

The battle between weight-loss drugs continues. While studies show semaglutide (sold under the brand names Ozempic and Wegovy ...

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

Interim results from the Phase III ESSENCE trial published in The New England Journal of Medicine show once-weekly ...

Once-weekly semaglutide 2.4 mg significantly reduced steatohepatitis and liver fibrosis symptoms among adults with metabolic ...

Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic ...

Ready to transform your body? It's possible with this program's personalized care, telehealth consultations, and semaglutide ...

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

Since its historic FDA approval in March 2024 as the first medication for the treatment of the prevalent liver disease ...